Search results
Title Prevencia irinotekanom indukovanej hnačky probiotickou zmesou Bifidobacterium a Lactobacillus rhamnosus u pacientov s metastatickým kolorektálnym karcinómom.Štúdia Probio-SK-006 Author Mego Michal SAVBIOMED - Biomedicínske centrum SAV Co-authors Daniš Radoslav Chovanec J. Jurišová Silvia Bystrický Branislav Pörsök Štefan Konkolovský Peter Václav Vladimír Wagnerová Mária Streško Marián Brezinová Bibiana Rečková Mária Šuteková D. Pazderová Natália Novisedlaková Mária Zomborská Eva Čierniková Soňa 1978- SAVBIOMED - Biomedicínske centrum SAV Svetlovská Daniela Drgoňa Ľuboš Action Bratislavské onkologické dni. LX. ročník : 4. - 6. október 2023 : Bratislava Source document Onkológia. Roč. 18, supl. 1 (2023), s. 53-54 Category AFH - Abstracts of papers from domestic conferences Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document abstrakt z podujatia Year 2023 
article
Title Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients Author Mego Michal Co-authors Daniš Radoslav Chovanec J. Jurišová Silvia Bystrický Branislav Pörsök Štefan Konkolovský Peter Václav Vladimír Wagnerová Mária Streško Marián Brezinová Bibiana Rečková Mária Suteková Dagmar Pazderová Natália Novisedlaková Mária Zomborská Eva Čierniková Soňa 1978- SAVBIOMED - Biomedicínske centrum SAV Svetlovská Daniela Drgoňa Ľuboš Source document Frontiers in Oncology. Vol. 13 (2023), art. no 1168654 Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2023 DOI 10.3389/fonc.2023.1168654 URL URL link File name Access Size Downloaded Type License Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients.pdf available 1.4 MB 5 Publisher's version article
Title Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium, BB-12 and Lactobacillus rhamnosus, LGG in colorectal cancer patients: The Probio SK 006-Slovak cooperative oncology group trial : e24109 Author Mego Michal Co-authors Daniš Radoslav Chovanec J. Jurišová Silvia Bystrický Branislav Pörsök Štefan Konkolovský Peter Václav Vladimír Wagnerová Mária Streško Marián Brezinová Bibiana Recková Mária Suteková Dagmar Pazderová Natália Novisedlaková Mária Zomborská Eva Čierniková Soňa 1978- SAVBIOMED - Biomedicínske centrum SAV Svetlovská Daniela Drgoňa Ľuboš Source document Journal of Clinical Oncology. Vol. 41, Issue 16 (2023), Suppl. S Category AEMA - Abstracts of scientific papers published in foreign impacted journals registered in Web of Science Core Collection or Scopus Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document abstrakt z podujatia Year 2023 article